13.2 Pathology and Laboratory

Why laboratory coding is a facility skill

Quick Answer: Report a CPT organ or disease panel when every defined component is performed. Use modifier 91 for a medically necessary same-day repeat of a clinical diagnostic laboratory test; do not use modifier 59 for that repeat, and do not bill a rerun that only confirms a result or fixes a bad specimen. Hospitals still report labs on the outpatient claim, but OPPS often packages them (conceptually status indicator Q4 or N—verify Addendum B). CLIA certification is required, and anatomic pathology often splits technical (hospital) from professional (pathologist, modifier 26).

Pathology and laboratory services sit in CPT 80000–89999. On the COC exam they are less about memorizing every chemistry code and more about facility logic: panels versus a la carte tests, collection versus the assay, clinical laboratory versus anatomic pathology, and OPPS packaging versus Clinical Laboratory Fee Schedule (CLFS) payment. Independent OpenExamPrep material for COC study walks those rules so a hospital coder can read a lab requisition the way an Outpatient Code Editor will.

Organ and disease panels versus individual tests

The CPT Professional codebook defines organ or disease oriented panels as specified groups of tests. The 2026 NCCI Policy Manual Chapter I, Section N, and Chapter X, Section C, are explicit: if the laboratory performs all tests included in one of those panels, the laboratory shall report the panel code. Chapter X's example is still the teaching pattern CMS uses: when cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol are all performed, the service is a lipid panel, not three stacked chemistry codes.

Use the panel when the tests are ordered as that panel or when the work performed matches the panel definition. Do not unbundle a comprehensive metabolic panel into its sodium, potassium, creatinine, and glucose pieces just to raise line-item count. Conversely, if the order is only a potassium and a creatinine, do not upcode to a panel the laboratory did not perform. NCCI contains PTP edits pairing each panel code (Column One) with each included component (Column Two). Those edits exist so a component billed with its own panel is denied unless a legitimate repeat-testing exception applies.

When a panel is reported and one component is later repeated the same day as a medically reasonable and necessary service, report the individual repeat test with the appropriate modifier (see modifier 91 below). Do not report a second panel for a single repeated analyte.

Collection: venipuncture and related traps

Venipuncture for a routine blood draw is a specimen-collection service, not the laboratory test. CPT 36415 describes collection of a venous blood specimen by venipuncture. Collection from a completely implanted venous access device or from an established central or peripheral catheter uses different codes in the 36591–36592 range; CMS coverage articles treat those as skilled access, not as substitutes for a peripheral stick. Do not report 36591 for a routine antecubital draw.

In the hospital outpatient setting, routine venipuncture is commonly packaged. Many facilities see status indicator N conceptually for 36415, meaning the collection is bundled into payment for the primary service or visit rather than paid as its own Ambulatory Payment Classification (APC). Do not treat that as a license to omit medically necessary lab tests from the claim; packaging is a payment result, not a documentation shortcut. Rural health clinic encounter-rate rules are a different payment system and are not a substitute for OPPS logic on a type of bill 013x claim.

Venipuncture is also not an NCCI permission slip to unbundle intravenous access that is integral to a procedure. If a line is placed only to draw labs during an encounter that already includes a more comprehensive vascular or infusion service, check NCCI before stacking collection codes.

Modifier 91 versus modifier 59

Modifier 91 is Repeat clinical diagnostic laboratory test. CPT and CMS both limit it to situations in which the same clinical diagnostic test must be repeated on the same date to obtain subsequent results that will be used in treatment—serial potassium during replacement, serial troponin during chest-pain evaluation, serial blood gases during respiratory failure. Medicare Claims Processing Manual Chapter 16, Section 100.5.1, which NCCI Chapter X cites, forbids using a repeat-test modifier when the laboratory reruns a test to confirm initial results, because of specimen or equipment problems, or when a normal one-time reportable result is all that is required.

Modifier 59 is Distinct procedural service. Its NCCI job is to show that two procedures were separate because of a different site, different encounter, or other distinct circumstance when no more specific modifier fits. It is the wrong first choice for a same-day medically necessary laboratory repeat of the same analyte. Using 59 to force payment of a panel component that was simply included in the morning panel is the error NCCI is built to catch. NCCI Chapter X notes that 59 or 91 may appear in the narrow panel-component bypass for a true same-day repeat; the clinical standard is still Chapter 16. If the more specific laboratory repeat modifier describes the facts, use 91.

NCCI Chapter X also distinguishes reflex tests from confirmation reruns. A positive red-cell antibody screen that proceeds to antibody identification, or a positive urine culture that proceeds to organism identification, is implicit follow-up with clinical value and is separately reportable when coded to the work performed. Repeating the same screen because the first run looked odd is not modifier 91 work.

CLIA

The Clinical Laboratory Improvement Amendments (CLIA) require certification before a facility bills laboratory tests. CMS Form CMS-116 is the application. Certificate types include Certificate of Waiver, Provider-Performed Microscopy, Certificate of Compliance, and Certificate of Accreditation. Waived tests are simple tests the Food and Drug Administration (FDA) categorizes as waived; they are not exempt from CLIA. A site that performs only waived testing still needs a Certificate of Waiver, must follow manufacturer instructions, and pays certificate fees. CMS's CLIA Program and Medicare Laboratory Services MLN product is the brochure-level source for those certificate rules.

On professional claims, many waived tests take modifier QW to show the test is waived under the billing laboratory's CLIA certificate. Hospital UB-04 billing uses the facility CLIA number in the appropriate form locator rather than turning every lab line into a QW exercise. If the hospital performs a non-waived test under only a waiver certificate, the claim is at risk regardless of CPT selection. Molecular pathology, surgical pathology, and most chemistry panels are not waived-test problems; point-of-care glucose, fecal occult blood, and some rapid influenza or streptococcal tests are the usual waiver conversations in outpatient departments.

OPPS packaging: think Q4 and N, then verify

Since calendar year 2014, CMS has packaged most clinical diagnostic laboratory tests in the hospital outpatient setting when they are furnished with other OPPS services. Calendar year 2016 introduced status indicator Q4 so the claims system can pay laboratory tests under the CLFS when a claim is essentially laboratory-only, and package them when they appear with specified separately payable OPPS services (CMS has described packaging when billed with services assigned status indicators such as J1, J2, S, T, V, Q1, Q2, or Q3). Status indicator N means items and services packaged into APC payment and not paid separately.

Do not invent a status indicator for a named test from memory. OPPS Addendum B and Addendum D1 are the lookup. Molecular pathology has historically been treated differently from routine chemistry. Preventive tests and some tests paid only on the CLFS may carry still other indicators (including A in some years). The COC skill is the concept: many labs on a 013x claim with a clinic visit, emergency visit, or procedure will not generate separate laboratory payment even when the CPT codes are correctly reported. A true lab-only outpatient claim may process under the CLFS through the Q4 logic. Packaging is not a reason to omit medically necessary tests from the claim; it is a reason not to expect a separate laboratory check.

Anatomic pathology and professional interpretation

Anatomic pathology (surgical pathology, cytopathology, some consultations) often has a professional/technical split even when clinical chemistry does not. The hospital reports the technical component on the UB-04 for processing and staining. The pathologist reports modifier 26 on the professional claim for interpretation and report when the pathologist is not billing globally. Clinical laboratory tests generally do not take modifier 26 unless the MPFS PC/TC indicator identifies a laboratory physician interpretation code (indicator 6 in the fee-schedule file). Do not append 26 to a basic metabolic panel.

Duplicate testing for the same analyte by two methods on the same date is not separately payable unless both methods are medically reasonable and necessary. NCCI Chapter X's hematology example is the teaching pattern: an automated hemogram with automated differential is not paired with a manual differential as a second paid differential unless the treating physician ordered the manual differential as a distinct medically necessary service. Examining a smear only to complete an automated count the laboratory already performed is not a second code.

Hospital outpatient scenario

A same-day surgery patient has a preoperative comprehensive metabolic panel at 07:00. At 14:00, after large-volume resuscitation, the surgeon orders a repeat potassium to guide replacement. The facility reports the panel once, the afternoon potassium with modifier 91, and the venipuncture according to OPPS packaging rules rather than as a second paid collection. Assigning modifier 59 to the potassium, unbundling the morning panel, or dropping the afternoon potassium because Q4 might package the chemistry still misstates the coding. Look up the current status indicator; report the tests that were performed.